112 related articles for article (PubMed ID: 8612304)
1. The integrity of cisplatin in aqueous and plasma ultrafiltrate media studied by 195Pt and 15N nuclear magnetic resonance.
Brière KM; Goel R; Shirazi FH; Stewart DJ; Smith CP
Cancer Chemother Pharmacol; 1996; 37(6):518-24. PubMed ID: 8612304
[TBL] [Abstract][Full Text] [Related]
2. Reactions of cisplatin hydrolytes with methionine, cysteine, and plasma ultrafiltrate studied by a combination of HPLC and NMR techniques.
el-Khateeb M; Appleton TG; Gahan LR; Charles BG; Berners-Price SJ; Bolton AM
J Inorg Biochem; 1999 Oct; 77(1-2):13-21. PubMed ID: 10626348
[TBL] [Abstract][Full Text] [Related]
3. Monitoring local disposition kinetics of carboplatin in vivo after subcutaneous injection in rats by means of 195Pt NMR.
Becker M; Port RE; Zabel HJ; Zeller WJ; Bachert P
J Magn Reson; 1998 Jul; 133(1):115-22. PubMed ID: 9654475
[TBL] [Abstract][Full Text] [Related]
4. Reaction of cis- and trans-[PtCl2(NH3)2] with reduced glutathione inside human red blood cells, studied by 1H and 15N-[1H] DEPT NMR.
Berners-Price SJ; Kuchel PW
J Inorg Biochem; 1990 Apr; 38(4):327-45. PubMed ID: 2332767
[TBL] [Abstract][Full Text] [Related]
5. Influence of dT20 and [d(AT)10]2 on cisplatin hydrolysis studied by two-dimensional [1H,15N] HMQC NMR spectroscopy.
Vinje J; Sletten E; Kozelka J
Chemistry; 2005 Jun; 11(13):3863-71. PubMed ID: 15827978
[TBL] [Abstract][Full Text] [Related]
6. Studies of the binding interactions of cis-diamminedichloroplatinum(II) with amines and nucleosides by nitrogen-15 nuclear magnetic resonance.
Nee M; Roberts JD
Biochemistry; 1982 Sep; 21(20):4920-6. PubMed ID: 6890382
[TBL] [Abstract][Full Text] [Related]
7. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.
Bierbach U; Sabat M; Farrell N
Inorg Chem; 2000 May; 39(9):1882-90. PubMed ID: 11428108
[TBL] [Abstract][Full Text] [Related]
8. The trans labilization of cis-[PtCl2(13CH3NH2)2] by glutathione can be monitored at physiological pH by [1H,13C] HSQC NMR.
Gibson D; Kasherman Y; Kowarski D; Freikman I
J Biol Inorg Chem; 2006 Mar; 11(2):179-88. PubMed ID: 16341898
[TBL] [Abstract][Full Text] [Related]
9. The reactions of cis-[Pt(NH3)2(H2O)2]2+ with L-(+)-cystathionine and seleno-L-methionine: potential relevance to the molecular basis of cisplatin toxicity.
Beaty JA; Jones MM; Ma L
Chem Res Toxicol; 1992; 5(5):647-53. PubMed ID: 1446004
[TBL] [Abstract][Full Text] [Related]
10. Development of HPLC conditions for valid determination of hydrolysis products of cisplatin.
El-Khateeb M; Appleton TG; Charles BG; Gahan LR
J Pharm Sci; 1999 Mar; 88(3):319-26. PubMed ID: 10052990
[TBL] [Abstract][Full Text] [Related]
11. Solvent effects and dynamic averaging of 195Pt NMR shielding in cisplatin derivatives.
Truflandier LA; Sutter K; Autschbach J
Inorg Chem; 2011 Mar; 50(5):1723-32. PubMed ID: 21204547
[TBL] [Abstract][Full Text] [Related]
12. Equilibrium and kinetic studies of the aquation of the dinuclear platinum complex [[trans-PtCl(NH3)2]2(mu-NH2(CH2)6NH2)]2+: pKa determinations of aqua ligands via [1H,15N] NMR spectroscopy.
Davies MS; Cox JW; Berners-Price SJ; Barklage W; Qu Y; Farrell N
Inorg Chem; 2000 Apr; 39(8):1710-5. PubMed ID: 12526558
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin Binding to Biological Ligands Revealed at the Encounter Complex Level by IR Action Spectroscopy.
Corinti D; Coletti C; Re N; Chiavarino B; Crestoni ME; Fornarini S
Chemistry; 2016 Mar; 22(11):3794-803. PubMed ID: 26749137
[TBL] [Abstract][Full Text] [Related]
14. Sugar interaction with biologically active cis-PtCl2(NH3)2 (anticancer) and its inactive trans isomer.
Tajmir-Riahi HA
Biophys Chem; 1987 Sep; 27(3):243-9. PubMed ID: 3663846
[TBL] [Abstract][Full Text] [Related]
15. Preparation of platinum(IV) complexes with dipeptide and diimine. X-ray crystal structure and 195Pt NMR spectra.
Watabe M; Fukuda H; Kitsukawa K; Nakajima H; Yukawa Y; Igarashi S; Fujii Y; Takayama T
J Inorg Biochem; 2006 Oct; 100(10):1653-9. PubMed ID: 16857262
[TBL] [Abstract][Full Text] [Related]
16. 195Pt NMR study of the speciation and preferential extraction of Pt(IV)-mixed halide complexes by diethylenetriamine-modified silica-based anion exchangers.
Kramer J; Koch KR
Inorg Chem; 2006 Sep; 45(19):7843-55. PubMed ID: 16961377
[TBL] [Abstract][Full Text] [Related]
17. [1H, 15N] heteronuclear single quantum coherence NMR study of the mechanism of aquation of platinum(IV) ammine complexes.
Davies MS; Hall MD; Berners-Price SJ; Hambley TW
Inorg Chem; 2008 Sep; 47(17):7673-80. PubMed ID: 18671390
[TBL] [Abstract][Full Text] [Related]
18. Studies on the interaction between cytochrome c and cis-PtCl2(NH3)2.
Lijuan J; Yu C; Guozi T; Wenxia T
J Inorg Biochem; 1997 Feb; 65(2):73-7. PubMed ID: 9014341
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin-DNA cross-link retro models with a chirality-neutral carrier ligand: evidence for the importance of "second-sphere communication".
Sullivan ST; Ciccarese A; Fanizzi FP; Marzilli LG
Inorg Chem; 2001 Jan; 40(3):455-62. PubMed ID: 11209601
[TBL] [Abstract][Full Text] [Related]
20. Platination of a GG site on single-stranded and double-stranded forms of a 14-base oligonucleotide with diaqua cisplatin followed by NMR and HPLC -- influence of the platinum ligands and base sequence on 5'-G versus 3'-G platination selectivity.
Reeder F; Guo Z; Murdoch PD; Corazza A; Hambley TW; Berners-Price SJ; Chottard JC; Sadler PJ
Eur J Biochem; 1997 Oct; 249(2):370-82. PubMed ID: 9370343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
